Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 475

1.

[Diagnostics and therapy for invasive fungal infections in an intensive care unit].

Koch S, Haefner H, Huenger F, Haase G, Wildberger J, Lemmen SW.

Anaesthesist. 2005 Oct;54(10):1047-64; quiz 1065-6. Review. German.

PMID:
16211405
[PubMed - indexed for MEDLINE]
2.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
[PubMed - indexed for MEDLINE]
3.

Patients at high risk of invasive fungal infections: when and how to treat.

Rüping MJ, Vehreschild JJ, Cornely OA.

Drugs. 2008;68(14):1941-62. Review.

PMID:
18778118
[PubMed - indexed for MEDLINE]
4.

Increasing fungal infections in the intensive care unit.

De Pauw BE.

Surg Infect (Larchmt). 2006;7 Suppl 2:S93-6. Review.

PMID:
16895517
[PubMed - indexed for MEDLINE]
5.

Invasive fungal infections in the intensive care unit.

Vazquez JA.

Semin Respir Crit Care Med. 2010 Feb;31(1):79-86. doi: 10.1055/s-0029-1246289. Epub 2010 Jan 25.

PMID:
20101550
[PubMed - indexed for MEDLINE]
6.

New developments in the diagnosis and management of invasive fungal infections.

De Marie S.

Haematologica. 2000 Jan;85(1):88-93. Review.

PMID:
10629598
[PubMed - indexed for MEDLINE]
Free Article
7.

Management of mycoses in surgical patients -- review of the literature.

Holzheimer RG, Dralle H.

Eur J Med Res. 2002 May 31;7(5):200-26. Review.

PMID:
12069912
[PubMed - indexed for MEDLINE]
8.

Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.

Devlin RK.

Adv Neonatal Care. 2006 Apr;6(2):68-77; quiz 78-9. Review.

PMID:
16618476
[PubMed - indexed for MEDLINE]
9.

Antifungal treatment strategies in high risk patients.

Rüping MJ, Vehreschild JJ, Cornely OA.

Mycoses. 2008 Sep;51 Suppl 2:46-51. doi: 10.1111/j.1439-0507.2008.01572.x.

PMID:
18721331
[PubMed - indexed for MEDLINE]
10.

A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.

Lortholary O, Charlemagne A, Bastides F, Chevalier P, Datry A, Gonzalves MF, Michel G, Tilleul P, Veber B, Herbrecht R.

J Antimicrob Chemother. 2004 Aug;54(2):456-64. Epub 2004 Jul 1.

PMID:
15231769
[PubMed - indexed for MEDLINE]
Free Article
11.

[Antifungal combination therapy in invasive fungal infections].

Gellen-Dautremer J, Lanternier F, Dannaoui E, Lortholary O.

Rev Med Interne. 2010 Jan;31(1):72-81. doi: 10.1016/j.revmed.2009.02.027. Epub 2009 Sep 19. French.

PMID:
19767130
[PubMed - indexed for MEDLINE]
12.

The place for itraconazole in treatment.

Maertens J, Boogaerts M.

J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i33-i38. Review.

PMID:
16120632
[PubMed - indexed for MEDLINE]
Free Article
13.

Caspofungin: a major breakthrough in treatment of systemic fungal infections.

Agarwal MB, Rathi SA, Ratho N, Subramanian R.

J Assoc Physicians India. 2006 Dec;54:943-8. Review.

PMID:
17334012
[PubMed - indexed for MEDLINE]
14.

[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].

Balwierz W.

Przegl Lek. 2004;61 Suppl 2:89-94. Polish.

PMID:
15686055
[PubMed - indexed for MEDLINE]
15.

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.

Sinkó J, Csomor J, Nikolova R, Lueff S, Kriván G, Reményi P, Bátai A, Masszi T.

Transpl Infect Dis. 2008 Apr;10(2):106-9. Epub 2007 Jul 1.

PMID:
17605727
[PubMed - indexed for MEDLINE]
16.

Invasive fungal infections: evolving challenges for diagnosis and therapeutics.

Ellis M.

Mol Immunol. 2002 May;38(12-13):947-57. Review.

PMID:
12009573
[PubMed - indexed for MEDLINE]
17.

The changing face of epidemiology of invasive fungal disease in Europe.

Lass-Flörl C.

Mycoses. 2009 May;52(3):197-205. Review.

PMID:
19391253
[PubMed - indexed for MEDLINE]
18.

Invasive fungal infections: the challenge continues.

Gullo A.

Drugs. 2009;69 Suppl 1:65-73. doi: 10.2165/11315530-000000000-00000. Review.

PMID:
19877737
[PubMed - indexed for MEDLINE]
19.

Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.

Metcalf SC, Dockrell DH.

J Infect. 2007 Oct;55(4):287-99. Epub 2007 Aug 13. Review.

PMID:
17697716
[PubMed - indexed for MEDLINE]
20.

Systemic antifungal therapy: new options, new challenges.

Wong-Beringer A, Kriengkauykiat J.

Pharmacotherapy. 2003 Nov;23(11):1441-62. Review.

PMID:
14620391
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk